Summary & Overview
CPT 28052: Metatarsophalangeal Joint Soft Tissue Biopsy
CPT code 28052 denotes a surgical biopsy of the metatarsophalangeal joint, performed to obtain soft tissue for diagnostic evaluation. Nationally, this code is relevant for orthopedic surgeons, podiatrists, and surgical teams managing toe and forefoot pathology where tissue diagnosis guides treatment decisions. Accurate coding ensures proper classification of operative services and supports patient records for post-procedure management.
Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical intent of the code, typical sites of service, and the common context in which the procedure is performed. The publication outlines benchmarking considerations, billing and documentation implications, and clinical context to help payers and providers align on coding expectations.
This summary provides an executive orientation to CPT code 28052: what the code represents, why it matters in surgical and diagnostic workflows, and what topics are covered in the full publication, including national benchmarking where available, relevant policy updates, and practical clinical context for use of the code.
Billing Code Overview
CPT code 28052 describes a surgical procedure in which an incision is made to open the metatarsophalangeal joint (the joint between the foot and toe) to obtain a soft tissue biopsy. This is a surgical biopsy of the metatarsophalangeal joint intended to collect tissue for diagnostic evaluation.
Service Type
- Surgical biopsy / operative procedure
Typical Site of Service
- Hospital operating room or ambulatory surgery center; may also be performed in an outpatient procedural suite depending on clinical setting and facility capabilities.
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient presents to a podiatry clinic with a persistent, painful swelling at the dorsal aspect of the first metatarsophalangeal joint. Conservative care including orthotics and NSAIDs over 6 weeks failed to relieve symptoms. On exam there is localized erythema, focal tenderness, and a palpable soft-tissue mass at the joint. Imaging (weight-bearing foot radiographs and ultrasound) suggests a soft-tissue lesion adjacent to the metatarsophalangeal joint suspicious for synovial proliferation or neoplasm. The provider schedules an outpatient operative procedure to perform an open biopsy of the metatarsophalangeal joint soft tissue.
Typical clinical workflow:
-
Preoperative evaluation in clinic with informed consent, medication reconciliation, and review of imaging.
-
Day-of-service verification, time-out, and local or regional anesthesia with sedation per protocol.
-
Surgical procedure performed in an ambulatory surgery center or hospital outpatient department: incision over the metatarsophalangeal joint, exposure of the lesion, excisional or incisional biopsy of soft tissue, hemostasis, and layered closure.
-
Specimen sent to pathology with appropriate labeling and documentation of site.
-
Postoperative recovery and discharge with wound care instructions and follow-up for pathology review and further definitive management as indicated.
Coding Specifications
| Modifier |
|---|